← Leaderboards
Paul Brian Dieffenbach
Brigham And Women'S Hospital
$822,124
Attributed
$822,124
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $169.8K · FY2016–21$200K$150K$100K$50K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$822,124 · 2
By mechanism
K08$679,360 · 1
F32$142,764 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Bradley Maron$8,442,424
- Peter Libby$39,585,619
- Laura Elizabeth Fredenburgh$4,191,382
- Stephen Y Chan$16,563,292
- Bradley Wertheim$1,908,343
Others in their field
Top investigators on “Hypoxia”
- James B Edson · Woods Hole Oceanographic Institution$110,367,520
- Albert J Plueddemann · Woods Hole Oceanographic Institution$110,367,520
- David Heimbrook · Leidos Biomedical Research, Inc.$41,862,534
- Nanduri R Prabhakar · Case Western Reserve University$32,967,177
- Zaver M Bhujwalla · Johns Hopkins University$30,055,665
- Donna M. Ferriero · University Of California, San Francisco$27,259,560
Research focus
HypoxiaIn VitroFeedbackHypoxemiaArterial StiffnessInvestigationCellsDisease ProgressionGenerationsHospitalsBehaviorBindingArteriesBiomedical EngineeringBlood VesselsAtomic Force MicroscopyAdvisory CommitteesCareer DevelopmentArterial RemodelingFutureHeart FailureCessation Of LifeCell ProliferationKnock-Down
Grant awards (6)
YAP/TAZ-mediated Mechanotransduction in Pulmonary Hypertension Pathogenesis$169,840
K08 · FY2021 · HL · contact PI
YAP/TAZ-mediated Mechanotransduction in Pulmonary Hypertension Pathogenesis$169,840
K08 · FY2020 · HL · contact PI
YAP/TAZ-mediated Mechanotransduction in Pulmonary Hypertension Pathogenesis$169,840
K08 · FY2019 · HL · contact PI
YAP/TAZ-mediated Mechanotransduction in Pulmonary Hypertension Pathogenesis$169,840
K08 · FY2018 · HL · contact PI
Pulmonary Vascular Cellular Response to Pathologic Matrix Stiffness in Pulmonary Arterial Hypertension$71,910
F32 · FY2017 · HL · contact PI
Pulmonary Vascular Cellular Response to Pathologic Matrix Stiffness in Pulmonary Arterial Hypertension$70,854
F32 · FY2016 · HL · contact PI